Nephria Bio

Nephria Bio is an early-stage biotech/medtech company developing Project Nephron, a wearable, portable artificial kidney system designed to transform hemodialysis treatment. The device aims to free patients from stationary clinic sessions by offering a lightweight, discreet wearable with features like dialysate recycling, remote patient monitoring, and AI-driven personalized therapy. Targeting the large and costly ESRD market, the company's value proposition centers on patient quality of life, potential clinical improvements via continuous therapy, and operational efficiencies for the healthcare system.

Integrated wearable artificial kidney system featuring miniaturized dialysis hardware, dialysate regeneration/recycling, a suite of sensors, and a generative AI engine (Adaptive Kidney Therapy) for personalized, real-time treatment adjustment and remote patient monitoring.

The wearable artificial kidney space has seen several academic and startup efforts over decades, but no commercially dominant product exists. Competitors include other early-stage ventures (e.g., Wearable Artificial Organs Inc., AWAK Technologies) and research consortia. The primary competition is the entrenched incumbent model of in-center dialysis, dominated by large providers like DaVita and Fresenius Medical Care, which have vast infrastructure and patient relationships.